CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ISU Abxis Company Limited Company Snapshot
ISU Abxis Company Limited operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares ISU Abxis Company Limited with three other companies in this sector in South Korea: Corestem Inc (2016 sales of 17.95 billion Korean Won [US$15.96 million] of which 86% was The clinical trial agent), Tego Science Inc (8.34 billion Korean Won [US$7.42 million] ), and Cellumed Co Ltd (9.81 billion Korean Won [US$8.72 million] ).

Sales Analysis. ISU Abxis Company Limited reported sales of 19.05 billion Korean Won (US$16.94 million) for the year ending December of 2016. This represents an increase of 66.1% versus 2015, when the company's sales were 11.47 billion Korean Won. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 528.0% in 2016, from 50.30 million Korean Won to 315.88 million Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ISU Abxis Company Limited
  Stock Performance Chart for ISU Abxis Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 8,200.00
(Figures in Korean Won)
1 Week -2.0%   13 Weeks 6.8%  
4 Weeks 2.9%   52 Weeks -33.1%  
 
ISU Abxis Company Limited Key Data:
  Ticker: 086890 Country: Korea (South)
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 19,054,716,993
(Year Ending Jan 2017).
Employees: 109
  Currency: Korean Won Market Cap: 161,957,642,400
  Fiscal Yr Ends: December Shares Outstanding: 19,750,932
  Share Type: Common Closely Held Shares: 8,571,973
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.